Randomized Clinical Trial
Copyright ©The Author(s) 2022.
World J Gastrointest Endosc. Dec 16, 2022; 14(12): 777-788
Published online Dec 16, 2022. doi: 10.4253/wjge.v14.i12.777
Table 1 Characteristics of the patient at baseline (n, %)
Characteristics
SNC (n = 154)
HFMG (n = 138)
Age (median, IQR)64, 56 to 7259, 48.5 to 69.5
Male71, 46.1%67, 48.6%
Weight, kg (mean, SD)76.4, 13.676.1, 14.8
BMI, kg/m2 (mean, SD)26.6, 4.126.4, 3.9
ASA classification, I/II/III14/67/73, 9.1%/43.5%/47.4%16/58/64, 11.6%/42.0%/46.4%
Mallampati class, I/II/III54/70/30, 35.1%/45.4%/19.5%48/70/20, 34.8%/50.7%/14.5%
Baseline oximetry, SpO2 (median, IQR)97%, 95% to 99%98%, 97% to 99%
Past medical history
Current smoking history14, 9.1%14, 10.1%
Obstructive sleep apnoea 8, 5.2%6, 4.3%
Hypertension 69, 44.8%46, 33.3%
Ischemic heart disease 19, 12.3%9, 6.5%
Diabetes mellitus 34, 22.1%33, 23.9%
Dyslipidemia 36, 23.4%26, 18.8%
Chronic obstructive pulmonary disease 8, 5.2%11, 8%
Asthma 9, 5.8%11, 8%
Cirrhosis 25, 16.2%34, 24.6%
Orthotopic liver transplantation 19, 12.3%25, 18.1%